NCT00667173View on ClinicalTrials.gov

A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Rosacea
Interventions
DRUG

IDP-115

Topical application for 12 weeks

DRUG

Vehicle

Topical application for 12 weeks

DRUG

Vehicle

Topical application for 12 weeks

Trial Locations (10)

30263

MedaPhase Inc., Newnan

33175

FXM Research Corp., Miami

35801

Medical Affiliated Research Center, Inc., Huntsville

45219

University Dermatology Consultants, Inc., Cincinnati

48202

Henry Ford Medical Center, Detroit

78759

DermResearch, Inc., Austin

80246

Cherry Creek Dermatology Research Inc., Denver

87106

Academic Dermatology Associates, Albuquerque

92123

Therapeutics Clinical Research, San Diego

94589

Solano Clinical Research, Vallejo

Sponsors
All Listed Sponsors
lead

Dow Pharmaceutical Sciences

INDUSTRY